EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies to overcome HIV drug resistance-current and future perspectives

Aura Temereanca, Simona Ruta

Frontiers in Microbiology · 16.02.2023 · 14

DOI: 10.3389/fmicb.2023.1133407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 16.02.2023. Verfasst von Aura Temereanca und 1 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The availability of combined antiretroviral therapy (cART) has revolutionized the course of HIV infection, suppressing HIV viremia, restoring the immune system, and improving the quality of life of HIV infected patients. However, the emergence of drug resistant and multidrug resistant strains remains an important contributor to cART failure, associated with a higher risk of HIV-disease progression and mortality. According to the latest WHO HIV Drug Resistance Report, the prevalence of acquired and transmitted HIV drug resistance in ART naive individuals has exponentially increased in the recent years, being an important obstacle in ending HIV-1 epidemic as a public health threat by 2030. The prevalence of three and four-class resistance is estimated to range from 5 to 10% in Europe and less than 3% in North America. The new drug development strategies are focused on improved safety and resistance profile within the existing antiretroviral classes, discovery of drugs with novel mechanisms of action (e.g., attachment/post-attachment inhibitors, capsid inhibitors, maturation inhibitors, nucleoside reverse transcriptase translocation inhibitors), combination therapies with improved adherence, and treatment simplification with infrequent dosing. This review highlight the current progress in the management of salvage therapy for patients with multidrug-resistant HIV-1 infection, discussing the recently approved and under development antiretroviral agents, as well as the new drug targets that are providing a new avenue for the development of therapeutic interventions in HIV infection.

Schlagwörter

Stichwörter der Autor:innen

HIV infectiondrug resistancenew drug targetsnewly approved antiretroviral agentspatients with multidrug-resistant HIV-1 infectionsalvage therapy

Autor:innen und Institutionen

  • Virology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Viral Emerging Diseases Department, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.

Zitieren

APA

Temereanca, A., & Ruta, S. (2023). Strategies to overcome HIV drug resistance-current and future perspectives. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1133407

Vancouver

Temereanca A, Ruta S. Strategies to overcome HIV drug resistance-current and future perspectives. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1133407

BibTeX
@article{Temereanca2023,
  author = {Temereanca, Aura and Ruta, Simona},
  title = {Strategies to overcome HIV drug resistance-current and future perspectives},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fmicb.2023.1133407}
}
Kostenlos starten →